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There has been a quiet revolution in
UK medical charities over the past
two decades. Increasing competition
for donations, adoption of new roles
relative to the state and private
sectors, and the requirement for
more accountability have all played
their part in the movement away
from a total reliance on volunteers to
a greater use of professional
expertise — not only in media
relations and fund-raising, but also in
the communication of science.
Since the recent comment in
Nature on sexism and nepotism in
science, previously unspoken reasons
for my (and no doubt many others’)
leaving academia have become an
acceptable topic for after-dinner
conversation; this article presents
some of my story. Like many people, I
had reached the stage in an academic
career when short-term grants were no
longer acceptable or secure enough,
but tenure seemed an elusive goal. As
an immunologist with a clinical bias, I
took an unusual career decision and
became Research Liaison Officer for
the UK’s Multiple Sclerosis Society.
Biomedical research funding in
the UK is more reliant than ever on
charity money. The 99 charities
belonging to the Association of
Medical Research Charities fund
more biomedical research than the
government’s Medical Research
Council. These charities have a
major role to play not only in funding
research, but also in influencing its
direction. In the UK, the Wellcome
Trust funds the lion’s share, but
other charities can have a huge
impact, often funding the majority of
research in one particular area.
Along with the need to account for
how money is spent on medical
research, there has been a clamouring
by donors and lay audiences for more
meaningful information about the
science ‘their charity’ is funding. For
many charities, particularly those that
are patient-based or relate to a specific
disease, ‘public understanding of
science’ has become a major focus. In
response to these changes, several
medical research charities now
employ scientists on their staff.
Medical research charities now
hire professionals to help explain
the science they sponsor 
Although the move to an office
comes gradually to most academics in
the course of their career, the
decision to leave the lab and look
after the research investment of a
high-profile charity is a large jump to
make. The return route is difficult, if
not impossible, at least partly for
personal reasons: charity work is less
synonymous with low pay than it
used to be, and the emotional
rewards can be immeasurable.
Despite the popular view,
charitable research administration
involves more than invoices and grant
applications. It is also about public
relations, interpretation and
information about science, as well as
policy, strategy and fund-raising.
Leaving your own personal research
agenda behind has its own rewards —
by stepping back, one can gain a
broad view of a field in its entirety.
The range of contacts also widens, in
my case to include people with
multiple sclerosis from all walks of
life, as well as health-care
professionals, scientists, and people in
industry, politics and public relations.
Charitable research funders have
always been responsive to researchers’
ideas, but there is increasingly a
fundamental change in attitude: in
order to nurture their investment,
charities are no longer relying solely
on researchers for direction; instead
they strategically plan how to get the
best impact. Debates rage over the
respective importance of people
versus places; centres versus
individual investigators; career and
training versus project grants;
innovation versus guaranteed results.
Funders with finite resources have
hard decisions to make.
All scientists these days need to
explain their work in accessible and
realistic terms. Increasingly, funders
are asking grant applicants for lay
summaries, which provide a start in
training researchers to explain their
work in simple terms. The trend by
scientists towards using the media is
also increasing. But because few
scientists are used to dealing with the
media, they are often surprised by
the public reaction. Writing, speaking
and broadcasting about multiple
sclerosis research for an audience of
non-scientists is one challenging part
of my job. The balance of making
science exciting and meaningful but
not promising ‘breakthroughs’ and
‘cures’ is hard to get right, particularly
when trying to raise money. Raising
false hopes is not only unfair on
people living with an illness for
which there is no current satisfactory
treatment, but also, when promises
are not fulfilled, results in
disillusionment with science and
scientists.
Because conventional science and
medicine cannot always meet the
needs of people with long-term
conditions, patients increasingly
experience a chasm between
expectation and delivery. The most
common criticism I hear is that the
needs of people with the disease are
not being addressed by biomedical
research. So, another aspect of my role
is to try and bridge the gap between
researchers and people with multiple
sclerosis. It’s a long way from planning
my own finite research project, so was
it a good move? Absolutely.
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